News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
674,365 Results
Type
Article (33713)
Company Profile (225)
Press Release (640406)
Multimedia
Podcasts (126)
Webinars (22)
Section
Business (191523)
Career Advice (1513)
Deals (33394)
Drug Delivery (126)
Drug Development (72567)
Employer Resources (135)
FDA (16310)
Job Trends (13868)
News (320372)
Policy (29021)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2270)
Accelerated approval (34)
Adcomms (20)
Allergies (158)
Alliances (49828)
ALS (184)
Alzheimer's disease (1524)
Antibody-drug conjugate (ADC) (382)
Approvals (16688)
Artificial intelligence (637)
Autoimmune disease (221)
Automation (50)
Bankruptcy (281)
Best Places to Work (11081)
BIOSECURE Act (17)
Biosimilars (202)
Biotechnology (152)
Bladder cancer (169)
Brain cancer (61)
Breast cancer (676)
Cancer (5246)
Cardiovascular disease (414)
Career advice (1312)
Career pathing (25)
CAR-T (311)
CDC (41)
Cell therapy (848)
Cervical cancer (37)
Clinical research (63495)
Collaboration (2014)
Company closure (5)
Compensation (1079)
Complete response letters (65)
COVID-19 (2181)
CRISPR (104)
C-suite (999)
Cystic fibrosis (146)
Data (6863)
Decentralized trials (2)
Denatured (37)
Depression (139)
Dermatology (55)
Diabetes (524)
Diagnostics (6862)
Digital health (54)
Diversity (8)
Diversity, equity & inclusion (32)
Drug discovery (307)
Drug pricing (167)
Drug shortages (32)
Duchenne muscular dystrophy (253)
Earnings (81374)
Editorial (41)
Employer branding (17)
Employer resources (122)
Events (108676)
Executive appointments (1072)
FDA (19777)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (12)
Frontotemporal dementia (28)
Funding (1645)
Gene editing (221)
Generative AI (57)
Gene therapy (668)
GLP-1 (910)
Government (3833)
Grass and pollen (7)
Guidances (392)
Healthcare (17387)
HIV (68)
Huntington's disease (43)
IgA nephropathy (85)
Immunology and inflammation (237)
Immuno-oncology (80)
Indications (154)
Infectious disease (2476)
Inflammatory bowel disease (201)
Inflation Reduction Act (14)
Influenza (129)
Intellectual property (276)
Interviews (225)
IPO (15529)
IRA (38)
Job creations (3182)
Job search strategy (1123)
JPM (56)
Kidney cancer (19)
Labor market (57)
Layoffs (489)
Leadership (27)
Legal (6457)
Liver cancer (100)
Longevity (26)
Lung cancer (713)
Lymphoma (383)
Machine learning (52)
Management (54)
Manufacturing (968)
MASH (174)
Medical device (14388)
Medtech (14471)
Mergers & acquisitions (19044)
Metabolic disorders (1318)
mRNA (184)
Multiple sclerosis (163)
NASH (18)
Neurodegenerative disease (358)
Neuropsychiatric disorders (86)
Neuroscience (2851)
Neurotech (1)
NextGen: Class of 2026 (5918)
Non-profit (3658)
Now hiring (39)
Obesity (592)
Opinion (271)
Ovarian cancer (181)
Pain (224)
Pancreatic cancer (250)
Parkinson's disease (334)
Partnered (31)
Patents (557)
Patient recruitment (594)
Peanut (57)
People (56545)
Pharmaceutical (50)
Pharmacy benefit managers (25)
Phase 1 (20333)
Phase 2 (27862)
Phase 3 (20890)
Pipeline (7100)
Policy (247)
Postmarket research (1933)
Preclinical (8168)
Press Release (72)
Prostate cancer (271)
Psychedelics (35)
Radiopharmaceuticals (314)
Rare diseases (953)
Real estate (5616)
Recruiting (54)
Regulatory (23491)
Reports (31)
Research institute (2140)
Resumes & cover letters (205)
Rett syndrome (33)
RNA editing (20)
RSV (78)
Schizophrenia (153)
Series A (282)
Series B (206)
Service/supplier (9)
Sickle cell disease (99)
Special edition (16)
Spinal muscular atrophy (148)
Sponsored (42)
Startups (3572)
State (2)
Stomach cancer (18)
Supply chain (121)
Tariffs (83)
The Weekly (87)
Vaccines (934)
Venture capital (81)
Weight loss (374)
Women's health (103)
Worklife (15)
Date
Last 7 days (630)
Last 30 days (2403)
Last 365 days (29416)
2026 (7894)
2025 (29687)
2024 (34428)
2023 (39235)
2022 (50243)
2021 (54186)
2020 (52167)
2019 (44274)
2018 (33543)
2017 (32119)
2016 (30368)
2015 (35815)
2014 (27579)
2013 (23058)
2012 (24950)
2011 (25682)
2010 (23316)
Location
Africa (654)
Alabama (90)
Alaska (7)
Arizona (283)
Arkansas (14)
Asia (40597)
Australia (6604)
California (11832)
Canada (3363)
China (1256)
Colorado (508)
Connecticut (517)
Delaware (354)
Europe (89094)
Florida (1810)
Georgia (413)
Hawaii (4)
Idaho (61)
Illinois (967)
India (84)
Indiana (574)
Iowa (20)
Japan (492)
Kansas (129)
Kentucky (40)
Louisiana (41)
Maine (84)
Maryland (1417)
Massachusetts (8496)
Michigan (361)
Minnesota (675)
Mississippi (7)
Missouri (148)
Montana (37)
Nebraska (25)
Nevada (130)
New Hampshire (89)
New Jersey (3226)
New Mexico (32)
New York (3131)
North Carolina (1600)
North Dakota (10)
Northern California (5861)
Ohio (365)
Oklahoma (25)
Oregon (41)
Pennsylvania (2349)
Puerto Rico (27)
Rhode Island (46)
South America (999)
South Carolina (77)
South Dakota (1)
Southern California (4657)
Tennessee (193)
Texas (1857)
United States (42368)
Utah (362)
Vermont (1)
Virginia (295)
Washington D.C. (72)
Washington State (951)
West Virginia (4)
Wisconsin (128)
Wyoming (2)
674,365 Results for "advanced technology products corporation atp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Atopia Therapeutics Reports Preclinical Proof-of-Concept of Lead Compound ATP-R13 in Atopic Dermatitis and Strengthens Patent Protection
- Preclinical in vivo efficacy data in atopic dermatitis extend previous PoC in allergic asthma - Positive opinion from the European Patent Office strengthens patent protection of ATP-R13 - Progress significantly enhances the strategic attractiveness of ATP-R13 as a broadly applicable, disease-modifying therapy across multiple allergic indications
January 20, 2026
·
1 min read
Press Releases
XingImaging Selected as the Imaging Core Lab for the Alzheimer’s Tau Platform (ATP) Phase II Clinical Trial
February 18, 2026
·
3 min read
Press Releases
Advanced Therapy Medicinal Products CDMO Market Size to Hit USD 53.11 Billion by 2035
April 1, 2026
·
1 min read
Press Releases
Chiesi and Bespak Partner to Advance Carbon Minimal Inhaler Production With UK Manufacturing Site
March 11, 2026
·
6 min read
Press Releases
Hubly Surgical awarded Breakthrough Technology Designation for Neurosurgical Products with Premier, Inc.
March 3, 2026
·
2 min read
Press Releases
Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization
March 26, 2026
·
4 min read
Genetown
MODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy Endpoints
Boston Scientific Corporation announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRM™ System,* the first modular cardiac rhythm management system that consists of the EMBLEM™ Subcutaneous Implantable Defibrillator System and the EMPOWER™ Leadless Pacemaker.
May 18, 2024
·
7 min read
Press Releases
Unnatural Products Raises $45 Million Series B Financing to Advance Macrocyclic Peptide Therapeutics
March 16, 2026
·
3 min read
Press Releases
FibroBiologics Announces Advances in Burn Treatment Using Proprietary Fibroblast Spheroid Technology
March 12, 2026
·
5 min read
Press Releases
Phio Pharmaceuticals Announces Agreement with U.S. cGMP Manufacturing Source for Drug Product, PH-762
A Critical Next Step in Advancing Phio’s PH-762 Program to Treat Cutaneous Carcinomas
March 30, 2026
·
4 min read
1 of 67,437
Next
